Sangamo Therapeutics, Inc. Stock
Stocks
SGMOQ
US8006771062
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
14:05:56 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.1100 USD | +8.70% |
|
-21.48% | -73.81% |
| Market Cap | 41.93M 37.32M 34.59M 31.34M 58.9M 3.97B 59.89M 415M 163M 2.08B 157M 154M 6.63B | P/E 2024 |
-2.1x | P/E 2025 | -0.96x |
|---|---|---|---|---|---|
| Enterprise Value | 47.77M 42.52M 39.41M 35.71M 67.12M 4.53B 68.24M 473M 186M 2.37B 179M 175M 7.56B | EV / Sales 2024 |
3.49x | EV / Sales 2025 | 3.72x |
| Free-Float |
99.07% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| SGMOQ | Delayed | |
London S.E.
| 0R1D | Delayed |
Last Transcript: Sangamo Therapeutics, Inc.
| 1 day | +8.70% | ||
| 1 week | -21.48% | ||
| Current month | -25.17% | ||
| 1 month | -22.15% | ||
| 3 months | +46.86% | ||
| 6 months | -59.27% | ||
| Current year | -73.81% |
| 1 week | 0.01 | 0.15 | |
| 1 month | 0.01 | 0.16 | |
| Current year | 0.01 | 0.6 | |
| 1 year | 0.01 | 0.69 | |
| 3 years | 0.01 | 3.18 | |
| 5 years | 0.01 | 11.49 | |
| 10 years | 0.01 | 27.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 63 | 2016-05-31 |
Nikunj Jain
DFI | Director of Finance/CFO | 47 | 2026-02-02 |
Phillip Ramsey
CTO | Chief Tech/Sci/R&D Officer | - | 2023-05-28 |
| Director | Title | Age | Since |
|---|---|---|---|
H. Parker
CHM | Chairman | 70 | 2017-05-31 |
Alexander Macrae
BRD | Director/Board Member | 63 | 2016-05-31 |
Robert Carey
BRD | Director/Board Member | 68 | 2016-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/25/26 | Tax | General Counsel | -4,036 | 0.0010% | ||
| 5/25/26 | Tax | Executive/Senior Manager | -4,036 | 0.0010% | ||
| 5/25/26 | Tax | Chief Executive Officer | -12,613 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.70% | -21.48% | -83.70% | -78.66% | 41.93M | ||
| +0.79% | -6.46% | +52.86% | +71.34% | 65.83B | ||
| +1.92% | +10.35% | +13.02% | +87.74% | 51.87B | ||
| +6.91% | +8.57% | +6.88% | +72.12% | 51.2B | ||
| +0.15% | +1.43% | +24.69% | +43.42% | 43.76B | ||
| +3.26% | +9.58% | +20.07% | +131.54% | 42.09B | ||
| +7.09% | +3.82% | +262.23% | +599.46% | 39.04B | ||
| -0.40% | +9.42% | +18.44% | +59.06% | 34B | ||
| +3.84% | -4.94% | +42.35% | +8.92% | 25.2B | ||
| +2.36% | +5.34% | +30.98% | +26.07% | 22.8B | ||
| Average | +3.49% | -2.79% | +38.78% | +102.10% | 37.58B | |
| Weighted average by Cap. | +2.87% | +0.61% | +50.73% | +124.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 57.8M 51.45M 47.68M 43.21M 81.2M 5.48B 82.56M 572M 225M 2.87B 217M 212M 9.14B | 39.55M 35.21M 32.63M 29.57M 55.57M 3.75B 56.5M 392M 154M 1.96B 148M 145M 6.26B |
| Net income | -97.94M -87.18M -80.8M -73.21M -138M -9.28B -140M -969M -381M -4.86B -367M -360M -15.49B | -123M -109M -101M -91.9M -173M -11.65B -176M -1.22B -478M -6.09B -461M -452M -19.44B |
| Net Debt | -11.35M -10.1M -9.36M -8.49M -15.95M -1.08B -16.22M -112M -44.14M -563M -42.58M -41.7M -1.8B | 5.85M 5.2M 4.82M 4.37M 8.21M 554M 8.35M 57.88M 22.74M 290M 21.93M 21.48M 925M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | US$0.1100 | +8.70% | 100,620 |
| 26-10-19 | US$0.1012 | -8.17% | 1,896,966 |
| 26-10-16 | US$0.1102 | -21.79% | 1,967,535 |
| 26-10-15 | US$0.1409 | +0.71% | 3,569,256 |
| 26-10-14 | US$0.1399 | -0.14% | 3,471,665 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SGMOQ Stock
Select your edition
All financial news and data tailored to specific country editions

















